Alvotech (ALVO)
4.89
+0.03
(+0.62%)
USD |
NASDAQ |
Nov 09, 09:31
Alvotech Market Cap : 1.745B for Nov. 9, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 06, 2026 | 1.734B |
| November 05, 2026 | 1.624B |
| November 04, 2026 | 1.666B |
| November 03, 2026 | 1.620B |
| November 02, 2026 | 1.599B |
| October 30, 2026 | 1.659B |
| October 29, 2026 | 1.745B |
| October 28, 2026 | 1.763B |
| October 27, 2026 | 1.695B |
| October 26, 2026 | 1.648B |
| October 23, 2026 | 1.634B |
| October 22, 2026 | 1.709B |
| October 21, 2026 | 1.830B |
| October 20, 2026 | 1.827B |
| October 19, 2026 | 1.795B |
| October 16, 2026 | 1.784B |
| October 15, 2026 | 1.895B |
| October 14, 2026 | 1.845B |
| October 13, 2026 | 1.920B |
| October 12, 2026 | 1.962B |
| October 09, 2026 | 2.062B |
| October 08, 2026 | 2.023B |
| October 07, 2026 | 2.087B |
| October 06, 2026 | 2.191B |
| October 05, 2026 | 2.180B |
| Date | Value |
|---|---|
| October 02, 2026 | 1.945B |
| October 01, 2026 | 2.005B |
| September 30, 2026 | 2.070B |
| September 29, 2026 | 2.112B |
| September 28, 2026 | 2.194B |
| September 25, 2026 | 2.052B |
| September 24, 2026 | 2.098B |
| September 23, 2026 | 2.073B |
| September 22, 2026 | 2.084B |
| September 21, 2026 | 2.098B |
| September 18, 2026 | 2.095B |
| September 17, 2026 | 1.905B |
| September 16, 2026 | 1.820B |
| September 15, 2026 | 1.791B |
| September 14, 2026 | 1.802B |
| September 11, 2026 | 1.888B |
| September 10, 2026 | 1.870B |
| September 09, 2026 | 1.859B |
| September 08, 2026 | 1.852B |
| September 04, 2026 | 1.898B |
| September 03, 2026 | 1.920B |
| September 02, 2026 | 1.905B |
| September 01, 2026 | 1.870B |
| August 31, 2026 | 1.852B |
| August 28, 2026 | 1.766B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Agenus, Inc. | 311.09M |
| Amgen, Inc. | 249.70B |
| Regeneron Pharmaceuticals, Inc. | 94.37B |
| Anika Therapeutics, Inc. | 197.40M |
| BioCryst Pharmaceuticals, Inc. | 1.991B |
Market Cap Related Metrics
| PS Ratio | 3.216 |
| Price | 4.89 |
| Earnings Yield | -11.40% |
| Operating PE Ratio | 35.24 |